Search Within

Anton Dobrin

Formats
  1. Journal Article (11)
  2. Meeting Abstract (8)
  3. Research Letter (1)
Groups
  1. Alumni (GSK) (20)
  2. GSK Faculty (20)
  3. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (20)
  4. MSK Grad Students (20)
  5. Sloan Kettering Institute Faculty (20)
  6. Center for Hematologic Malignancies (19)

More Groups

People
  1. Michel Sadelain (19)
  2. Zeguo Zhao (9)
  3. Mohamad Hamieh (7)
  4. Jorge Mansilla-Soto (6)
  5. Nayan Jain (6)
  6. Yuzhe Shi (6)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (4)
  4. 2022 (4)
  5. 2021 (3)
  6. 2019 (2)

More Years

Publications
  1. Nature (5)
  2. Molecular Therapy (3)
  3. Cancer Research (2)
  4. Journal for ImmunoTherapy of Cancer (2)
  5. Nature Medicine (2)
  6. Blood (1)

More Publications

Publishers
  1. Nature Publishing Group (10)
  2. American Association for Cancer Research (3)
  3. Biomed Central Ltd (2)
  4. American Society of Hematology (1)
  5. Cell Press (1)
  6. Mary Ann Liebert, Inc (1)

More Publishers

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • HIV immune evasin Nef enhances allogeneic CAR T cell potency
    Journal Article

    Perica, K.; Kotchetkov, I. S.; Mansilla-Soto, J.; Ehrich, F.; Herrera, K.; Shi, Y.; Dobrin, A.; Gönen, M.; Sadelain, M.
    Nature (2025)

    Fulltext@MSK | Save
  • CAR T-cell-derived TNF drives cytokine release syndrome and enhances M1 macrophage differentiation
    Meeting Abstract

    Lindenbergh, P. L.; Giavridis, T.; Vivier, O.; Lopez, M.; Dobrin, A.; Sadelain, M.
    Molecular Therapy (2024)

    Fulltext@MSK | Save
  • GLUT1 overexpression enhances CAR T cell metabolic fitness and anti-tumor efficacy
    Journal Article

    Shi, Y.; Kotchetkov, I. S.; Dobrin, A.; Hanina, S. A.; Rajasekhar, V. K.; Healey, J. H.; Sadelain, M.
    Molecular Therapy (2024)

    Fulltext@MSK | Save
  • Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies
    Journal Article

    Dobrin, A.; Lindenbergh, P. L.; Shi, Y.; Perica, K.; Xie, H.; Jain, N.; Chow, A.; Wolchok, J. D.; Merghoub, T.; Sadelain, M.; more...
    Nature Cancer (2024)

    Fulltext@MSK | Save
  • Disruption of SUV39H1-mediated H3K9 methylation sustains CAR T-cell function
    Journal Article

    Jain, N.; Zhao, Z.; Koche, R. P.; Antelope, C.; Gozlan, Y.; Montalbano, A.; Brocks, D.; Lopez, M.; Dobrin, A.; Shi, Y.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Synthetic dual-costimulation for TCR and TCR-like targeted cell therapies
    Meeting Abstract

    Dobrin, A.; Xie, H.; Perica, K.; Jain, N.; Sadelain, M.; Hamieh, M.
    Human Gene Therapy (2023)

    Fulltext@MSK | Save
  • Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
    Journal Article

    Rojas, L. A.; Sethna, Z.; Soares, K. C.; Olcese, C.; Pang, N.; Patterson, E.; Lihm, J.; Ceglia, N.; Guasp, P.; Chu, A.; more...
    Nature (2023)

    Fulltext@MSK | Save
  • TET2 guards against unchecked BATF3-induced CAR T cell expansion
    Journal Article

    Jain, N.; Zhao, Z.; Feucht, J.; Koche, R.; Iyer, A.; Dobrin, A.; Mansilla-Soto, J.; Yang, J.; Zhan, Y.; Lopez, M.; more...
    Nature (2023)

    Fulltext@MSK | Save
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • SUV39H1 disruption enhances the persistence and anti-tumor efficacy of CD28-costimulated human CAR T cells
    Meeting Abstract

    Jain, N.; Zhao, Z.; Koche, R.; Gozlan, Y.; Brocks, D.; Raveh-Sadka, T.; Wells, D.; Dobrin, A.; Shi, Y.; Lopez, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save